The Effects of the CF Carrier State on the Kidneys and Pancreas

Launched by PHILIP POLGREEN · Jul 22, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at the effects of being a carrier of cystic fibrosis (CF) on the kidneys and pancreas. Researchers believe that people who carry the CF gene may have a higher risk of developing certain health issues related to these organs, even if they do not have CF themselves. To explore this, the study will invite CF carriers and healthy individuals (who have never been tested for CF) to participate in a single visit where they will answer survey questions and undergo lab tests. Participants will also collect urine and stool samples at home to send for additional testing.

To be eligible for this study, you need to be a confirmed CF carrier or a healthy control with no prior CF tests. Unfortunately, people currently diagnosed with CF, those who cannot speak English, pregnant individuals, or those taking diabetes medications cannot participate. If you join the trial, you'll help researchers gather important information that could improve our understanding of health risks for CF carriers. The trial is currently recruiting participants aged between 6 and 74 years, and everyone is welcome regardless of gender.

Gender

ALL

Eligibility criteria

• CF Carrier Inclusion Criteria:
• • A CF Carrier identified via genetic testing
• Control Inclusion Criteria:
• • No previous CF carrier test results
• Exclusion Criteria:
• • CF patient status
• • Unable to speak English
• • Currently pregnant
• • Unable to provide written informed consent
• • Prisoner status
• • Currently taking any medications for the treatment of diabetes